CD19 and B-cell chronic lymphocytic leukemia: While a number of pathophysiological processes such as microenvironmental signaling occur in secondary lymphoid organs of CLL patients (Burger & Gribben, 2014), the comprehensive analysis of different epigenetic layers required the acquisition of sufficient numbers of CD19+ B cells and was therefore conducted from peripheral blood.